UPL's $4.2 bn purchase of ArystaLifeScience to deepen its global footprint

TPG joins hand with Abu Dhabi Investment Authority to back the transaction, JP Morgan is deal adviser

UPL Ltd announced on Friday that its wholly-owned subsidiary, UPL Corporation Ltd, has signed a definitive agreement with Platform Specialty Products Corporation to acquire ArystaLifeScience Inc. and its subsidiaries for a cash consideration of about $4.2 billion.

Tokyo-headquartered ArystaLifeScience is a global provider of innovative crop protection solutions, including bio-solutions and seed treatment. A wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and TPG have partnered with UPL Corp to support the proposed acquisition. The deal is subject to customary closing conditions and regulatory approvals.

This acquisition will create New UPL and fulfil the company's objective of creating an